Hepatopulmonary syndrome (HPS) patients with a pa(O2) of < 8 kPa should consider liver transplantation as studies have shown significant improvement in oxygenation within the first year. Transjugular intrahepatic portosystemic shunt (TIPS) is not recommended as it may worsen HPS. Long-term oxygen therapy is commonly used to alleviate symptoms but does not cure HPS. Lung transplantation is not a recommended treatment. Spironolactone and furosemide, commonly used for decompensated chronic liver disease with ascites, have not been proven effective for HPS management.

Treatment and Management of Spinal Cord Compression

Spinal cord compression is a serious condition that requires prompt treatment and management. Dexamethasone is a commonly used medication for this condition and can be administered via any available route. However, there is no significant advantage to giving it intravenously over orally. Patients with MSCC should be offered 16 mg of dexamethasone as soon as possible after assessment, except for those with a significant suspicion of lymphoma. The possibility of spinal surgery does not affect the prescribing of corticosteroids in this situation.

Spinal stabilisation surgery should be urgently considered for patients with spinal metastases and imaging evidence of structural spinal failure with spinal instability, as well as those with mechanical pain resistant to conventional analgesia, even if they have been completely paralysed for more than 24 hours. Preoperative radiotherapy is not recommended, but postoperative fractionated radiotherapy can be offered to patients with a satisfactory outcome once the wound has healed.

Patients with MSCC should be assessed at least once a day for changes in bowel and bladder function. Bladder dysfunction should be managed with a urinary catheter on free drainage, although this should not be performed automatically on all MSCC patients. Overall, prompt treatment and management are crucial for patients with spinal cord compression to improve their outcomes and quality of life.

If the ultrasound characteristics of a new thyroid nodule are benign, there is no requirement for an FNAC. In the case of a large goitre where the extent cannot be seen on ultrasound, a CT or MRI of the neck may be beneficial. To rule out a toxic thyroid nodule, thyroid function tests are necessary. Autoantibodies can assist in the diagnosis of Grave’s disease.

Thyroid cancer rarely causes hyperthyroidism or hypothyroidism as it does not usually secrete thyroid hormones. The most common type of thyroid cancer is papillary carcinoma, which is often found in young females and has an excellent prognosis. Follicular carcinoma is less common, while medullary carcinoma is a cancer of the parafollicular cells that secrete calcitonin and is associated with multiple endocrine neoplasia type 2. Anaplastic carcinoma is rare and not responsive to treatment, causing pressure symptoms. Lymphoma is also rare and associated with Hashimoto’s thyroiditis.

Management of papillary and follicular cancer involves a total thyroidectomy followed by radioiodine to kill residual cells. Yearly thyroglobulin levels are monitored to detect early recurrent disease. Papillary carcinoma usually contains a mixture of papillary and colloidal filled follicles, while follicular adenoma presents as a solitary thyroid nodule and malignancy can only be excluded on formal histological assessment. Follicular carcinoma may appear macroscopically encapsulated, but microscopically capsular invasion is seen. Medullary carcinoma is associated with raised serum calcitonin levels and familial genetic disease in up to 20% of cases. Anaplastic carcinoma is most common in elderly females and is treated by resection where possible, with palliation achieved through isthmusectomy and radiotherapy. Chemotherapy is ineffective.

The most probable diagnosis for the patient is adult polycystic kidney disease (APKD), which is a common autosomal-dominant disease caused by a gene defect on chromosome 16. It typically presents in the fourth or fifth decade of life and is characterized by haematuria, hypertension, loin pain, urinary tract infections, and kidney disease. In this case, the patient’s condition was likely complicated by haemorrhage into a cyst, causing the pain. APKD is also associated with hepatic, pancreatic, and ovarian cysts, subarachnoid haemorrhage, renal calculi, mitral valve prolapse, polycythaemia, and anaemia of chronic kidney disease.

Aortic valve prolapse is a common valvular condition in APKD, but it is more likely to affect the mitral valve than the aortic valve. Berry aneurysms are present in only 20-25% of APKD cases, which is lower than the previously stated 50-75%. Gallstones are unlikely to be the underlying cause of the patient’s symptoms, as there is no association between APKD and gallstones, and there are no symptoms to suggest this diagnosis. While diabetes mellitus may coexist with APKD, it is more likely to be maturity onset diabetes of the young (MODY), which would have presented before the age of 42.

When it comes to detecting colorectal cancer, conventional endoscopy is the most sensitive method, followed by CT colonoscopy and labelled white cell scan. However, CT colonoscopy has the advantage of being less invasive and has a higher chance of detecting previously undetected lesions. Labelled white cell scan is particularly useful for detecting large volume bleeding.

Understanding Angiodysplasia: A Vascular Deformity of the Gastrointestinal Tract

Angiodysplasia is a medical condition characterized by a vascular deformity in the gastrointestinal tract, which can lead to bleeding and iron deficiency anemia. This condition is commonly observed in elderly patients and is often associated with aortic stenosis, although this is still a topic of debate among medical professionals.

To diagnose angiodysplasia, doctors may perform a colonoscopy or mesenteric angiography if the patient is acutely bleeding. Once diagnosed, the condition can be managed through various treatments, including endoscopic cautery or argon plasma coagulation. Antifibrinolytics such as Tranexamic acid and oestrogens may also be used to manage the symptoms of angiodysplasia.

In summary, angiodysplasia is a vascular deformity that can cause bleeding and anemia in the gastrointestinal tract. While it is commonly seen in elderly patients and may be associated with aortic stenosis, it can be managed through various treatments such as endoscopic cautery, antifibrinolytics, and oestrogens. Early diagnosis and treatment can help prevent complications and improve the patient’s quality of life.

Understanding Diabetes Insipidus and Conn Syndrome

Diabetes insipidus (DI) is a condition that can be caused by reduced vasopressin (ADH) secretion from the posterior pituitary gland (cranial DI) or renal resistance to its action (nephrogenic DI). It is important to distinguish DI from psychogenic polydipsia, which is excessive fluid intake usually due to psychiatric disturbance. In DI, there should be high plasma and low urine osmolality. The diagnosis is confirmed by the water deprivation test, where the patient is fluid-restricted for 8 hours and blood/urine osmolality and weight are measured hourly. In cranial DI, the urine osmolality should rise to > 660 mOsmol/kg after desmopressin, whereas there will be little to no response in nephrogenic DI. The causes of nephrogenic DI include drugs (e.g. lithium), hypokalaemia and hypercalcaemia, or it can be inherited. Management mainly involves treating or removing the cause, although bendroflumethiazide can be used. Cranial DI will respond to intranasal desmopressin.

Conn syndrome, on the other hand, is a cause of hypertension, but with no abnormality in urine osmolality. It is important to distinguish it from DI as the treatment and management differ.

In summary, understanding the differences between DI and Conn syndrome is crucial in providing the appropriate treatment and management for patients.

If bubbling is observed in a chest drain inserted to drain an empyema, it may indicate the occurrence of a bronchopleural fistula. This refers to an abnormal connection between the bronchi and the pleural space, which can be caused by complicated infections such as empyema. Therefore, unexpected bubbling during chest drain insertion for empyema should raise suspicion of this complication.

The options of iatrogenic diaphragmatic injury, iatrogenic lung injury, and infection with gas-producing organisms are incorrect. While these are potential complications of chest drain insertion, they are less likely in this case due to the use of ultrasound guidance and the large volume of fluid. Additionally, the minimal fluid after 24 hours and ongoing bubbling suggest a structural problem such as a bronchopleural fistula, rather than an infection or injury.

Chest Drain Insertion and Management

A chest drain is a tube that is inserted into the pleural cavity to allow the movement of air or liquid out of the cavity. It is indicated in cases of pleural effusion, pneumothorax, empyema, haemothorax, haemopneumothorax, chylothorax, and some cases of penetrating chest wall injury in ventilated patients. However, insertion of a chest drain is relatively contraindicated in patients with INR > 1.3, platelet count < 75, pulmonary bullae, or pleural adhesions. To insert a chest drain, the patient should be positioned in a supine position or at a 45º angle, and the area should be anaesthetised using local anaesthetic injection. The drainage tube should then be inserted using a Seldinger technique and secured with either a straight stitch or an adhesive dressing. Positioning can be confirmed by aspiration of fluid from the drainage tubing or on chest x-ray. Complications that may occur during chest drain insertion include failure of insertion, bleeding, infection, penetration of the lung, and re-expansion pulmonary oedema. Patients should be advised of these complications during the consent process. In the event of concerns regarding re-expansion pulmonary oedema, the chest drain should be clamped, and an urgent chest x-ray should be obtained. The removal of the chest drain is dependent upon the indication for insertion. In cases of fluid drainage from the pleural cavity, the drain should be removed when there has been no output for > 24 hours and imaging shows resolution of the fluid collection. In cases of pneumothorax, the drain should be removed when it is no longer bubbling spontaneously or when the patient coughs and ideally when imaging shows resolution of the pneumothorax. Drains inserted in cases of penetrating chest injury should be reviewed by the specialist to confirm an appropriate time for removal.

Overall, chest drain insertion and management should be approached on an individual case basis, with consideration of the patient’s specific circumstances and potential contraindications.

Patients who abuse androgens often hide the truth about their use of exogenous testosterone. The symptoms of reduced testicular volume and elevated haemoglobin levels suggest androgen abuse, which is common among bodybuilders. Androgen abuse can also cause abnormal liver function and lipid abnormalities, such as a reduction in HDL cholesterol and an increase in LDL cholesterol, which can increase the risk of cardiovascular disease. Androgen administration can activate the haemostatic system, leading to an increase in levels of prothrombin fragment 1, antithrombin III, and protein S, and a reduction in levels of TPA and its inhibitor. The presence of androgenisation with reduced testicular volume suggests exogenous testosterone administration, which can be detected by measuring the testosterone/epitestosterone ratio.

The most likely cause of sudden deterioration in renal function is acute interstitial nephritis, which is inflammation of the renal tubulo-interstitium due to a hypersensitivity reaction to drugs, with NSAIDs being the most common cause. Other drugs that can cause this include antibiotics, diuretics, and cimetidine. Symptoms include acute renal failure, fever, arthralgia, and skin rashes, with eosinophilia, raised serum IgE, and eosinophiluria often present. Treatment involves withdrawal of the offending drug and may require dialysis. ACE inhibitors can also cause acute deterioration in renal function, mainly in patients with bilateral renovascular disease, and may increase serum potassium. There is no evidence of urinary tract infection or digoxin as a cause of the deterioration.

Tetanus is the only vaccine that is safe to administer during pregnancy as it is based on toxoids. Other vaccines, such as BCG, rubella, varicella zoster, and yellow fever, are live attenuated vaccines and should not be given during pregnancy due to the potential risk of fetal infection. However, some of these vaccines may be considered on a risk-benefit basis if the mother must travel to an endemic area. In general, only killed or toxoid-based vaccines, such as influenza, hepatitis B, and whooping cough, are considered safe during pregnancy. It is important to weigh the risks and benefits of any medication during pregnancy.

Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

Syndrome of inappropriate antidiuretic hormone (SIADH) is a condition characterized by hyponatremia, high urine sodium, and osmolality. This condition can be caused by various factors, including certain medications such as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, sulphonylureas, thiazides, and carbamazepine. Additionally, SIADH can also be caused by medical conditions such as pneumonias, meningitis, Guillain-Barré syndrome, trauma, and malignancy.

It is important to note that lithium, a medication commonly used to treat bipolar disorder, can cause diabetes insipidus (DI) rather than SIADH. DI is a condition characterized by excessive thirst and urination due to the inability of the kidneys to concentrate urine.

the causes of SIADH is crucial in its diagnosis and management. Treatment may involve addressing the underlying cause, restricting fluid intake, and administering medications to increase sodium levels in the blood.

Hepatic Venous Pressure Gradient and its Clinical Significance

The hepatic venous pressure gradient (HVPG) is a crucial parameter used to assess portal hypertension. A normal HVPG ranges from 1-5 mmHg, indicating that portal hypertension is not caused by post-sinusoidal intrinsic liver disease or post-hepatic venous obstruction. To calculate HVPG, the free hepatic venous pressure and the wedged hepatic venous pressure are subtracted, which are obtained through hepatic venous catheterization. The goal of treatment is to reduce HVPG by 20% or to less than 12 mmHg using non-selective beta blockers. If this is not achievable, endoscopic variceal ligation may be considered.

Pre-sinusoidal portal hypertension is caused by obstruction before the sinusoids. Sarcoidosis is a rare cause of pre-sinusoidal portal hypertension, particularly in white children. Schistosomiasis is the leading cause of pre-sinusoidal hypertension worldwide, but it is unlikely in an Irish boy. Thrombosis of the portal vein is a well-known complication in premature neonates due to umbilical vein cannulation during neonatal intensive care.

HVPG and its clinical significance is essential in the diagnosis and management of portal hypertension. Accurate assessment of HVPG can guide treatment decisions and improve patient outcomes.

Although the patient is now stable after experiencing pancreatitis, it is recommended to discontinue the use of GLP-1 agonist medication due to studies linking it to pancreatitis. Additionally, patients with a history of pancreatitis should not be prescribed this medication. Therefore, liraglutide should be stopped.

As for metformin, it may be necessary to discontinue it during times of increased risk of tissue hypoxia, such as during the acute phase of pancreatitis. However, there is no indication that it should be discontinued in the long term. Furthermore, recent guidance suggests that metformin can be initiated in patients with a glomerular filtration rate as low as 45 ml/min, even in those with renal impairment.

NICE has updated its guidance on the management of type 2 diabetes mellitus (T2DM) in 2022 to reflect advances in drug therapy and improved evidence regarding newer therapies such as SGLT-2 inhibitors. For the average patient taking metformin for T2DM, lifestyle changes and titrating up metformin to aim for a HbA1c of 48 mmol/mol (6.5%) is recommended. A second drug should only be added if the HbA1c rises to 58 mmol/mol (7.5%). Dietary advice includes encouraging high fiber, low glycemic index sources of carbohydrates, controlling intake of saturated fats and trans fatty acids, and initial target weight loss of 5-10% in overweight individuals.

Individual HbA1c targets should be agreed upon with patients to encourage motivation, and HbA1c should be checked every 3-6 months until stable, then 6 monthly. Targets should be relaxed on a case-by-case basis, with particular consideration for older or frail adults with type 2 diabetes. Metformin remains the first-line drug of choice, and SGLT-2 inhibitors should be given in addition to metformin if the patient has a high risk of developing cardiovascular disease (CVD), established CVD, or chronic heart failure. If metformin is contraindicated, SGLT-2 monotherapy or a DPP-4 inhibitor, pioglitazone, or sulfonylurea may be used.

Further drug therapy options depend on individual clinical circumstances and patient preference. Dual therapy options include adding a DPP-4 inhibitor, pioglitazone, sulfonylurea, or SGLT-2 inhibitor (if NICE criteria are met). If a patient does not achieve control on dual therapy, triple therapy options include adding a sulfonylurea or GLP-1 mimetic. GLP-1 mimetics should only be added to insulin under specialist care. Blood pressure targets are the same as for patients without type 2 diabetes, and ACE inhibitors or ARBs are first-line for hypertension. Antiplatelets should not be offered unless a patient has existing cardiovascular disease, and only patients with a 10-year cardiovascular risk > 10% should be offered a statin.

Both carbon monoxide and cyanide poisoning can be treated with oxygen.

The human body naturally detoxifies cyanide through an enzyme called rhodanese, which is present in various tissues, especially the liver and muscles. Rhodanese converts cyanide into thiocyanate, a water-soluble molecule that is eliminated through urine.

However, in cases of poisoning, the amount of cyanide overwhelms the rhodanese enzyme, making it unable to eliminate the excess cyanide molecules.

Understanding Cyanide Poisoning

Cyanide is a toxic substance that can be found in insecticides, photograph development, and metal production. When ingested, cyanide can inhibit the enzyme cytochrome c oxidase, which can lead to the cessation of the mitochondrial electron transfer chain. This can result in a range of symptoms, depending on the severity and duration of exposure.

The presentation of cyanide poisoning can vary, but some classical features include brick-red skin and a smell of bitter almonds. Acute symptoms may include hypoxia, hypotension, headache, and confusion. Chronic exposure can lead to ataxia, peripheral neuropathy, and dermatitis.

If someone is suspected of cyanide poisoning, supportive measures such as administering 100% oxygen should be taken immediately. Definitive treatment involves the use of hydroxocobalamin, which is given intravenously. A combination of inhaled amyl nitrite, intravenous sodium nitrite, and intravenous sodium thiosulfate may also be used.

It is important to seek medical attention immediately if cyanide poisoning is suspected, as prompt treatment can be life-saving.

Dyskaryosis or dysplasia refers to precancerous changes in cervical cells, which can be classified as borderline, mild, moderate, or severe. A smear result may also refer to CIN 1, CIN 2, or CIN 3, which relate to the thickness of the skin covering the cervix that is affected. Women with moderate or severe precancerous changes are at significant risk of developing cervical cancer and should be referred for colposcopy. A repeat smear in six months is indicated for mild cell changes or CIN 1, as these cells can sometimes revert to normal spontaneously. The HPV vaccine is offered to girls aged 12-13 as a preventative measure against HPV types 16 and 18, which are responsible for up to 70% of cervical cancer, as well as types 6 and 11 which cause genital warts. Cone biopsies may be necessary if abnormal cells extend deep into the cervix. Patients with abnormal colposcopy results are routinely tested for HPV virus. All women are invited for routine screening every 3-5 years depending on their age, but immediate referral for colposcopy is required for those with moderate or severe dysplasia.

It is not advisable to discontinue metformin for this patient. However, the total daily dose of metformin should be divided into two: one-third (500mg) to be taken before sunrise (Suhoor) and two-thirds (1g) after sunset (Iftar). If the patient’s blood glucose levels are well-managed with metformin alone, there is no need to switch to a sulphonylurea.

Managing Diabetes Mellitus During Ramadan

Type 2 diabetes mellitus is more prevalent in people of Asian ethnicity, including a significant number of Muslim patients in the UK. With Ramadan falling in the long days of summer, it is crucial to provide appropriate advice to Muslim patients to ensure they can safely observe their fast. While it is a personal decision whether to fast, it is worth noting that people with chronic conditions are exempt from fasting or may delay it to shorter days in winter. However, many Muslim patients with diabetes do not consider themselves exempt from fasting. Around 79% of Muslim patients with type 2 diabetes mellitus fast during Ramadan.

To help patients with type 2 diabetes mellitus fast safely, they should consume a meal containing long-acting carbohydrates before sunrise (Suhoor). Patients should also be given a blood glucose monitor to check their glucose levels, especially if they feel unwell. For patients taking metformin, the dose should be split one-third before sunrise (Suhoor) and two-thirds after sunset (Iftar). For those taking sulfonylureas, the expert consensus is to switch to once-daily preparations after sunset. For patients taking twice-daily preparations such as gliclazide, a larger proportion of the dose should be taken after sunset. No adjustment is necessary for patients taking pioglitazone. Diabetes UK and the Muslim Council of Britain have an excellent patient information leaflet that explores these options in more detail.

Managing diabetes mellitus during Ramadan is crucial to ensure Muslim patients with type 2 diabetes mellitus can safely observe their fast. It is important to provide appropriate advice to patients, including consuming a meal containing long-acting carbohydrates before sunrise, checking glucose levels regularly, and adjusting medication doses accordingly.

Pacemaker Syndrome

Pacemaker syndrome, also known as AV desynchronisation, is a condition that affects individuals who have been fitted with a pacemaker and have inadequate AV synchronisation. The symptoms of this syndrome include dizziness, syncope, hypotension, and peripheral oedema, which can lead to heart failure. Patients who are at a higher risk of developing AV desynchronisation are those with low sinus rate, hypotension, or low compliance ventricles before the insertion of the pacemaker.

ECG changes can show AV desynchronisation with small P waves. The treatment for this condition involves replacing the device with a dual-chamber device. It is important to note that there are no specific diagnostic criteria for pacemaker syndrome.

It is essential to differentiate pacemaker syndrome from other conditions that may present with similar symptoms. For instance, hyperkalaemia can cause ECG changes similar to those seen in pacemaker syndrome. Mobitz type 2 heart block shows intermittent non-conductive p waves without PR elongation compared to type 1 where there is PR interval prolongation before a beat is dropped. T wave inversion can be non-specific but when accompanied with chest pain is a sign of evolving infarction.

In conclusion, pacemaker syndrome is a condition that affects individuals with pacemakers and inadequate AV synchronisation. It is important to identify the symptoms and differentiate them from other conditions to provide appropriate treatment.

The Royal College of Physicians (RCP) and NICE have published guidelines on the diagnosis and management of patients following a stroke. The guidelines provide recommendations for the management of acute stroke, including maintaining normal levels of blood glucose, hydration, oxygen saturation, and temperature. Blood pressure should not be lowered in the acute phase unless there are complications. Aspirin should be given as soon as possible if a haemorrhagic stroke has been excluded. Anticoagulants should not be started until brain imaging has excluded haemorrhage, and usually not until 14 days have passed from the onset of an ischaemic stroke. If the cholesterol is > 3.5 mmol/l, patients should be commenced on a statin.

Thrombolysis with alteplase should only be given if it is administered within 4.5 hours of onset of stroke symptoms and haemorrhage has been definitively excluded. There are absolute and relative contraindications to thrombolysis, including previous intracranial haemorrhage, intracranial neoplasm, and active bleeding. Mechanical thrombectomy is a new treatment option for patients with an acute ischaemic stroke. NICE recommends considering thrombectomy together with intravenous thrombolysis for people last known to be well up to 24 hours previously.

Secondary prevention recommendations from NICE include the use of clopidogrel and dipyridamole. Clopidogrel is recommended ahead of combination use of aspirin plus modified-release dipyridamole in people who have had an ischaemic stroke. Aspirin plus MR dipyridamole is recommended after an ischaemic stroke only if clopidogrel is contraindicated or not tolerated. MR dipyridamole alone is recommended after an ischaemic stroke only if aspirin or clopidogrel are contraindicated or not tolerated. Carotid artery endarterectomy should only be considered if carotid stenosis is greater than 70% according to ECST criteria or greater than 50% according to NASCET criteria.

Abnormal Connection between Right and Left Sides of the Heart

The oxygen saturation levels in the right atrium (RA) and superior vena cava (SVC) should be equal, but there is a noticeable increase in oxygen saturation at the low RA level. This can only be due to the addition of oxygenated blood to the deoxygenated blood in the right heart circulation, which indicates an abnormal connection between the right and left sides of the heart. The location of the step-up suggests that the patient may have a primum atrial septal defect (ASD), which is a type of defect that occurs low down in the atrioventricular (A-V) septum, just above the A-V valves. These types of defects can also affect the function of the anterior leaflet of the mitral valve, leading to mitral regurgitation. Additionally, the patient’s right ventricular pressures are high, which is more commonly associated with primum ASDs.

Overall, the patient’s symptoms and test results suggest that they have an abnormal connection between the right and left sides of their heart, likely due to a primum ASD. This defect can cause an increase in oxygen saturation levels at the low RA level and may also affect the function of the mitral valve, leading to mitral regurgitation. The patient’s high right ventricular pressures further support this diagnosis.

Interpretation of Laboratory Tests in Vasculitis

A positive anti-nuclear antibody (ANA) result is almost always present in systemic lupus erythematosus, while a negative ANA makes anti-double stranded antibody unlikely. In suspected systemic vasculitis, anti-neutrophil cytoplasmic antibodies (ANCA) should always be done. In polyarteritis nodosa (PAN) and microscopic polyangiitis, anti-cytoplasmic antibodies directed against myeloperoxidase (pANCA) will produce a perinuclear staining pattern, while in granulomatosis with polyangiitis, a cytoplasmic pattern is likely. A positive hepatitis B surface antigen is associated with PAN of medium and small arteries. Polyclonal gammaglobulinaemia on serum protein electrophoresis is expected in systemic inflammatory disease and does not aid diagnosis. The rest of the tests listed would give non-specific changes and not be helpful in establishing a diagnosis.

The patient in this case has necrotising vasculitis affecting the skin, kidneys, gut, and joints, along with systemic symptoms of fever, malaise, and weight loss. The most likely diagnosis is polyarteritis nodosa associated with hepatitis B, given the negative serology for systemic lupus erythematosus and negative blood cultures for endocarditis-related arthropathy. Henoch-Schönlein purpura is more common in children, and although rheumatoid factor is positive, there is no clear involvement of the proximal interphalangeal and metacarpophalangeal joints, which is typical in rheumatoid arthritis.

The Likely Cause of Acute LVF in a Smoker with Subclinical Hyperthyroidism and Elevated Glucose Concentrations

The patient’s acute admission with left ventricular failure (LVF) is most likely due to coronary artery disease, given their long-term history of smoking. Although thyroid tests reveal subclinical hyperthyroidism, it is unlikely to be the cause of the acute LVF. However, it may contribute to the development of atrial fibrillation (AF), which could be exacerbated by underlying ischaemic heart disease (IHD). Additionally, elevated glucose concentrations in stress circumstances do not necessarily indicate diabetes mellitus (DM), but if the patient were diabetic, it would further support the presence of CAD without overt chest pain symptoms. Overall, these factors suggest that the patient’s LVF is likely a result of underlying CAD, potentially exacerbated by other comorbidities.

Bronchioloalveolar Cell Carcinoma of the Lung

Bronchioloalveolar cell carcinoma of the lung is a type of primary lung cancer that accounts for approximately 5% of cases. Patients with this cancer may experience a classic symptom of producing a large amount of clear frothy sputum, which can be up to one litre a day, but this is a late manifestation. Other symptoms include dyspnoea, weight loss, and chest pain. About half of patients are diagnosed through routine chest X-rays, which typically show a peripheral lesion. This cancer is named after its growth pattern along the alveolar walls without destroying them, and it is classified as an adenocarcinoma. Unfortunately, for those whose tumour is not resectable, the prognosis is poor.

Management of Renal Anaemia

This patient is likely suffering from renal associated anaemia due to a deficiency of erythropoietin. According to Renal Association guidance, it is important to ensure that the patient is iron replete before considering an erythropoiesis-stimulating agent. Therefore, the patient’s iron stores should be checked before starting erythropoietin. Although the reticulocyte count may be elevated, it would not change the management of the patient.

While a blood transfusion may increase the haemoglobin levels temporarily, it is not a viable long-term solution for managing renal anaemia. A marrow biopsy may be considered if there is a lack of response to iron and erythropoietin, but it is likely to be normal given the normal white count and platelet count.

In summary, the management of renal anaemia involves ensuring that the patient is iron replete before considering erythropoietin. Blood transfusions are not a long-term solution, and a marrow biopsy may be considered if there is a lack of response to treatment.

Cryptococcal Meningo-Encephalitis: A Fungal Infection in Immunocompromised Patients

Cryptococcus meningo-encephalitis is a severe fungal infection caused by Cryptococcus neoformans, which affects patients with weakened cell-mediated immunity. This illness is considered an AIDS-defining condition and is commonly observed when the CD4 count is below 100. The symptoms of this infection develop gradually over one to two weeks. The diagnosis of Cryptococcal meningo-encephalitis is made by examining the cerebrospinal fluid (CSF) with India ink, which reveals the presence of encapsulated yeast forms.

The treatment of Cryptococcal meningo-encephalitis involves the use of intravenous amphotericin B, which may be combined with flucytosine in some cases. In certain instances, a prolonged course of fluconazole may be prescribed. It is crucial to diagnose and treat this infection promptly to prevent severe complications.

Clozapine is known to cause constipation and intestinal obstruction, which is a serious but often overlooked complication. This patient’s recent prescription of clozapine, along with their history of constipation and current symptoms of acute abdominal pain, vomiting, and distension, suggest that they are likely suffering from intestinal obstruction. While bezoars and appendicitis are possible explanations for the symptoms, there is no evidence to support these diagnoses in this particular case. It is important to consider medication side effects when evaluating a patient’s condition, especially when there is a recent change in medication.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These agents have a significant advantage over traditional antipsychotics in that they cause fewer extrapyramidal side-effects. However, atypical antipsychotics can still cause adverse effects such as weight gain, hyperprolactinaemia, and clozapine-associated agranulocytosis. Elderly patients who take antipsychotics are at an increased risk of stroke and venous thromboembolism, according to the Medicines and Healthcare products Regulatory Agency.

Clozapine is one of the first atypical antipsychotics to be developed, but it carries a significant risk of agranulocytosis. Therefore, full blood count monitoring is essential during treatment. Clozapine should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Clozapine can cause adverse effects such as reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

A lymphocytic pleocytosis is not a typical finding in common bacterial infections like Pneumococcus and Meningococcus, which usually result in a neutrophilic pleocytosis. However, it can be seen in cases of partially treated bacterial infections, Lyme disease, tuberculosis, and Cryptococcus.

The patient’s symptoms of arthralgia, peripheral neuropathy, and first degree heart block suggest Lyme disease, which is further supported by the CSF results. Lyme disease is caused by Borrelia burgdorferi, and intravenous ceftriaxone is the preferred treatment for disseminated cases.

While a partially treated bacterial infection could also cause the CSF results seen in this patient, it is important to note that they have not yet received any treatment.

Raised Lymphocytes in Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a clear liquid that surrounds the brain and spinal cord. Normal values of CSF include pressure, protein, glucose, and cell count. However, raised lymphocytes in CSF can indicate various conditions such as viral meningitis/encephalitis, TB meningitis, partially treated bacterial meningitis, Lyme disease, Behcet’s, SLE, lymphoma, and leukemia.

When the lymphocyte count in CSF is higher than the normal range, it can be a sign of an underlying infection or inflammation in the brain or spinal cord. Viral meningitis/encephalitis, TB meningitis, and partially treated bacterial meningitis are some of the infections that can cause raised lymphocytes in CSF. Lyme disease, Behcet’s, and SLE are autoimmune disorders that can also lead to increased lymphocytes in CSF.

In rare cases, raised lymphocytes in CSF can be a sign of lymphoma or leukemia. These are types of cancer that affect the lymphatic system and can spread to the brain and spinal cord. Therefore, it is important to consult a healthcare professional if there are any symptoms or concerns related to raised lymphocytes in CSF.

Cryoglobulinemia as the Underlying Cause of Systemic Vasculitis

The patient’s medical history suggests systemic vasculitis with mononeuritis multiplex, purpuric rash, and haematuria. It is crucial to rule out conditions that can mimic vasculitis, such as infective endocarditis. However, the normal echocardiogram and negative blood cultures make this unlikely. Polyarteritis nodosa can present with the same clinical picture, but the marked consumption of C4 and a strongly positive rheumatoid factor indicate cryoglobulinemia as the underlying cause.

Cryoglobulins are immunoglobulins that precipitate in the cold and can be classified into three types. Type I cryoglobulinemia is associated with haematological diseases, while Type II and Type III cryoglobulinemia can be linked to many connective tissue disorders, chronic infections, and most importantly, hepatitis C infection, which should always be excluded. Treatment of cryoglobulinemia involves plasmaphoresis, high dose steroids, and cyclophosphamide.

The presence of a positive rheumatoid factor can also indicate other conditions such as rheumatoid arthritis, Sjögren’s syndrome, mixed connective tissue disease, systemic lupus erythematosus, and polymyositis/dermatomyositis. The percentage of patients with a positive rheumatoid factor varies among these conditions.

ECG Axis Deviation: Causes of Left and Right Deviation

Electrocardiogram (ECG) axis deviation refers to the direction of the electrical activity of the heart. A normal axis is between -30 and +90 degrees. Deviation from this range can indicate underlying cardiac or pulmonary conditions.

Left axis deviation (LAD) can be caused by left anterior hemiblock, left bundle branch block, inferior myocardial infarction, Wolff-Parkinson-White syndrome with a right-sided accessory pathway, hyperkalaemia, congenital heart defects such as ostium primum atrial septal defect (ASD) and tricuspid atresia, and minor LAD in obese individuals.

On the other hand, right axis deviation (RAD) can be caused by right ventricular hypertrophy, left posterior hemiblock, lateral myocardial infarction, chronic lung disease leading to cor pulmonale, pulmonary embolism, ostium secundum ASD, Wolff-Parkinson-White syndrome with a left-sided accessory pathway, and minor RAD in tall individuals. It is also normal in infants less than one year old.

It is important to note that Wolff-Parkinson-White syndrome is a common cause of both LAD and RAD, depending on the location of the accessory pathway. Understanding the causes of ECG axis deviation can aid in the diagnosis and management of underlying conditions.

First-line Insulin Therapy for Type 2 Diabetes

In accordance with NICE guidelines, the recommended first-line insulin therapy for type 2 diabetes is a humane isophane insulin, also known as Neutral Protamine Hagedorn (NPH) insulin. These intermediate-acting insulins are typically administered once daily at night or twice a day. However, long-acting insulin analogues or biphasic mixed preparations may also be considered as alternative options.

Long-acting insulin analogues may be more suitable for individuals who struggle with administering twice-daily NPH insulin injections, as they only require a once-daily injection. On the other hand, biphasic mixed preparations are recommended for individuals with poor diabetic control, indicated by an HbA1c level above 75 mmol/mol.

For patients who are able to self-inject and have an HbA1c level significantly below 75 mmol/mol, NPH/human isophane insulin would be the most appropriate initial insulin choice. It is important to follow NICE guidelines when selecting insulin therapy for type 2 diabetes to ensure optimal patient outcomes.

Post-Partum Thyroiditis: A Possible Cause of Psychotic Presentation

Post-partum thyroiditis is a condition that affects around 1/3 of women after delivery, presenting with hyperthyroidism 1-4 months post-delivery. In rare cases, thyrotoxicosis may be associated with a psychotic presentation. The hyperthyroidism is followed by hypothyroidism, and the majority of patients recover from the condition. However, 1/3 of women develop permanent hypothyroidism, requiring permanent thyroid replacement.

Hashimoto’s thyroiditis, on the other hand, presents with hypothyroidism, making it less likely in this case. Graves’ disease is associated with TSH receptor antibodies, but this patient does not have any other features of the disease. Atrophic thyroiditis is rare and occurs in women aged 40-60 years, associated with hypothyroidism.

Postnatal depression can be excluded because the abnormal thyroid function tests suggest that the psychological disturbance is related to thyrotoxicosis. Therefore, post-partum thyroiditis should be considered as a possible cause of psychotic presentation in post-partum women.